| | Authors | Number (age) | miRNA related to osteoporosis |
| | Feichtinger et al. [14] | 36 patients ( years) | miR-29b-3p, miR-324-3p, and miR-550a-3p | | Kocijan et al. [13] | 36 patients ( years) and 39 control subjects ( years) | miR-155-5p, miR-181c-5p, miR-203a, miR-330-3p, and miR-942-5p, | | Ramirez-Salazar et al. [12] | 20 patients with fracture, 46 patients with osteoporosis, 28 patients with osteopenia, and 42 control | hsa-miR-885-5p, hsa-miR-17-5p, hsa-miR-1227-3p, hsa-miR-23b-3p, hsa-miR-140-3p, hsa-miR-139-5p, hsa-miR-197-3p | | Yavropoulou et al. [11] | 35 postmenopausal patients with fracture ( years), 35 postmenopausal patients without fracture ( years), and 30 control subjects ( years) | miR-21-5p, miR-23a, miR-29a-3p, miR-124-3p, and miR-2861 | | Weilner et al. [10] | 19 patients with fracture and 18 control | miR-22-3p, miR-328-3p, and let-7g-5p | | Seeliger et al. [8] | 10 osteoporotic samples and 10 control | miR-21, miR-23a, miR-24, miR-93, miR-100, miR-122a, miR-124a, miR-125b, and miR-148a | | Li et al. [9] | 120 postmenopausal women | miR-21 and miR-133a | | Ma et al. [36] | 21 patients with fracture, 86 cases with osteopenia or osteoporosis, and 14 control | miR-181c-5p, miR-497-5p | | The current study | 352 subjects (139 men, 213 women; mean age: yrs) | miR-195 (female) and miR-150 (male) |
|
|
